Acute and mid-term combined hormone replacement therapy improves endothelial function in post-menopausal women with angina and angiographically normal coronary arteries

• Published in: European heart journal 2001-11, Vol.22 (22), p.2116-2124
• Main Authors: Sitges, M, Heras, M, Roig, E, Durán, M, Masotti, M, Zurbano, M.J, Roqué, M, Sanz, G
• Format: Article
• Language: English
• Subjects: Aged; Angina Pectoris - drug therapy; Brachial Artery - diagnostic imaging; Brachial Artery - drug effects; Circadian Rhythm; Coronary Angiography; Coronary Vessels - drug effects; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Endothelial function; Endothelium, Vascular - diagnostic imaging; Endothelium, Vascular - drug effects; Endothelium, Vascular - physiology; Estradiol - administration & dosage; Estradiol - blood; Estradiol - therapeutic use; Estrogen Replacement Therapy; Female; hormone replacement therapy; Humans; Middle Aged; oestradiol; syndrome X; Vascular Patency - drug effects; Women's Health
• ISSN: 0195-668X; 1522-9645
• DOI: 10.1053/euhj.2001.2631

Aims and background Coronary endothelial dysfunction improves after acute oestradiol treatment in women with angina and normal coronary angiograms. We sought to analyse whether this effect is also seen in the peripheral circulation and whether it is sustained after a mid-term period of treatment. Methods We studied 20 women with angina, signs suggestive of myocardial ischaemia and normal coronary angiograms. In five of them, coronary and peripheral endothelial functions were studied at baseline. Brachial artery flow-mediated dilation was reanalysed after 24h of transdermal oestradiol treatment. In the other 15 women, brachial artery vasoreactivity was studied at baseline and after a 6-week period of treatment with transdermal oestradiol and medroxyprogesterone (HRT) or placebo in a double-blinded crossover fashion. Results An abnormal coronary artery response to acetylcholine was observed in all women as well as impaired brachial flow-mediated dilation. Brachial flow-mediated dilation significantly increased after 24h of oestradiol treatment (4·8±0·8% vs 0·06±0·6%,P